Alphamab Oncology Presented Multiple Clinical Data on Biparatopic HER2-targeting ADC JSKN003 at ESMO Congress 202520/10/2025PR Newswire
Biparatopic HER2-targeting ADC JSKN003 Was Granted Another Breakthrough Therapy Designation for HER2-Positive Advanced Colorectal Cancer20/10/2025PR Newswire
Chengdu CATANIA’s Tower 2 Debuts Globally: A 222-Meter-High Sky Residence Redefining Global Luxury Living.20/10/2025PR Newswire
MILESEEY GenePro G1 Named to TIME’s “The Best Inventions of 2025: Special Mentions”20/10/2025PR Newswire
Kelun-Biotech Presents Positive Phase 3 Data for Trastuzumab Botidotin Compared to T-DM1 at 2025 ESMO20/10/2025PR Newswire
Accord Plasma B.V. Expands Global Plasma Therapy Capabilities with Acquisition of Prothya Biosolutions20/10/2025PR Newswire
Accord Plasma B.V. ขยายขีดความสามารถด้านการบำบัดด้วยพลาสมาระดับโลก ด้วยการเข้าซื้อกิจการ Prothya Biosolutions20/10/2025PR Newswire
From Corporate Social Responsibility To Global Consensus: Chery’s “Ride Green Life” Unites the World for a Sustainable Future20/10/2025PR Newswire
KLN Drives Libya’s Wellhead Platform A Project Toward Completion, One of the Mediterranean Sea’s Largest Offshore EPCI Projects to Bolster Energy Infrastructure20/10/2025PR Newswire
